According to a large-scale study published in Nature Medicine<\/i>, depression is not only a healthcare challenge but also one of the primary challenges facing the global economy. Based on data from the World Bank and 154 countries, researchers estimate that economic losses caused by depression between 2025 and 2050 will reach $12 trillion. If suicide cases related to depression are added to this statistics, the economic burden increases to $14 trillion.<\/p>\n
In absolute terms, the largest economic burden falls on the United States (over $4 trillion), followed by China ($2 trillion) and the United Kingdom ($475 billion). Regarding the share of losses relative to national economies, the most severe proportional conditions are recorded in North America, Europe, and Sub-Saharan Africa, while in per capita terms, Switzerland, Ireland, and Norway lose the largest amounts due to depression (approximately $12,000 each).<\/p>\n
The main driving forces behind economic losses are not direct medical expenses, but rather a reduction in the workforce and diminished productivity (absenteeism, loss of concentration, and leaving employment). Unlike cancer and other severe physical illnesses, which often manifest in later stages of life, depression primarily begins during adolescence and early adulthood\u2014precisely when an individual is obtaining education and building a career. Consequently, the negative impact of the condition on human productivity accumulates over decades.<\/p>\n
The scale of the problem is also driven by an unprecedented number of patients. According to 2023 data, approximately 322 million people worldwide lived with depression. The situation was catastrophically aggravated by the COVID-19 pandemic, during the very first year of which the global prevalence of depression and anxiety increased by 25\u201327%. Particularly alarming is the statistic concerning children and adolescents, nearly a third of whom (31%) exhibited pronounced depressive symptoms during the pandemic.<\/p>\n
Researchers emphasize that expenditures on depression treatment represent a long-term strategic investment. Data show that every $1 invested in the treatment of depression and anxiety returns $4 to the economy through improvements in health and productivity. To mitigate global losses, scientists advise governments to integrate mental health services into primary healthcare and massively introduce accessible, evidence-based therapies (including online cognitive-behavioral therapy).<\/p>\n